Monday, March 16, 2009

Court report

About Court Report: Every week http://www.patentdocs.org/ report briefly on recently filed biotech and pharma cases, and they select few interesting cases for periodic monitoring.

Sanofi-Aventis U.S. LLC et al. v. Ebewe Pharma Ges.M.B.H. NFG.KG3:09-cv-01116; filed March 11, 2009 in the District Court of New Jersey (oxaliplatin for injection)

Abbott Laboratories et al. v. Lupin Ltd. et al.1:09-cv-00152; filed March 6, 2009 in the District Court of Delaware (niacin)

Abbott Laboratories et al. v Lupin Ltd. et al.1:09-cv-00564; filed March 6, 2009 in the District Court of Maryland (Niacin)

Genzyme Corp. v. Lupin Ltd. et al.1:09-cv-00563; filed March 6, 2009 in the District Court of Maryland (sevelamer hydrochloride)

Abbott Laboratories et al. v. Lupin Ltd. et al.2:09-cv-01007; filed March 6, 2009 in the District Court of New Jersey (fenofibrate)

Elan Pharma International Ltd. et al. v. Lupin Ltd. et al.2:09-cv-01008; filed March 6, 2009 in the District Court of New Jersey (fenofibrate)

Procter & Gamble Co. et al. v. Apotex Inc. et al.1:09-cv-00281; filed March 5, 2009 in the Southern District of Indiana (Risedronate sodium)

The detailed complaint and the other details can be read here.

No comments: